Literature DB >> 16467076

Well-defined melanoma antigens as progression markers for melanoma: insights into differential expression and host response based on stage.

F Stephen Hodi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16467076     DOI： 10.1158/1078-0432.CCR-05-2616

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  10 in total

1.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Authors:  Adam I Riker; Steven A Enkemann; Oystein Fodstad; Suhu Liu; Suping Ren; Christopher Morris; Yaguang Xi; Paul Howell; Brandon Metge; Rajeev S Samant; Lalita A Shevde; Wenbin Li; Steven Eschrich; Adil Daud; Jingfang Ju; Jaime Matta
Journal:  BMC Med Genomics       Date:  2008-04-28       Impact factor: 3.063

2.  BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma.

Authors:  Mirela Kremenovic; Alfred A Chan; Bing Feng; Lukas Bäriswyl; Steve Robatel; Thomas Gruber; Li Tang; Delphine J Lee; Mirjam Schenk
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

3.  Aire deficiency promotes TRP-1-specific immune rejection of melanoma.

Authors:  Meng-Lei Zhu; Anil Nagavalli; Maureen A Su
Journal:  Cancer Res       Date:  2013-01-31       Impact factor: 12.701

Review 4.  Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.

Authors:  Darryl A Oble; Robert Loewe; Ping Yu; Martin C Mihm
Journal:  Cancer Immun       Date:  2009-04-02

5.  Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma.

Authors:  Marta Osorio; Elias Gracia; Edmundo Reigosa; Julio Hernandez; Ana de la Torre; Giselle Saurez; Kirenia Perez; Carmen Viada; Meylán Cepeda; Adriana Carr; Yisel Avila; Migdalia Rodríguez; Luis E Fernandez
Journal:  Cancer Manag Res       Date:  2012-10-05       Impact factor: 3.989

6.  Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodies.

Authors:  Amy E Gilbert; Panagiotis Karagiannis; Tihomir Dodev; Alexander Koers; Katie Lacy; Debra H Josephs; Pooja Takhar; Jenny L C Geh; Ciaran Healy; Mark Harries; Katharine M Acland; Sarah M Rudman; Rebecca L Beavil; Philip J Blower; Andrew J Beavil; Hannah J Gould; James Spicer; Frank O Nestle; Sophia N Karagiannis
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

7.  Therapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasis.

Authors:  Eun-Young Lee; Kyong-Su Park; Yae Jin Yoon; Jaewook Lee; Hyung-Geun Moon; Su Chul Jang; Kyoung-Ho Choi; Yoon-Keun Kim; Yong Song Gho
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

8.  Evaluation of transgene expression characteristics and DNA vaccination against melanoma metastasis of an intravenously injected ternary complex with biodegradable dendrigraft poly-L-lysine in mice.

Authors:  Yukinobu Kodama; Ayako Tokunaga; Junya Hashizume; Hiroo Nakagawa; Hitomi Harasawa; Tomoaki Kurosaki; Tadahiro Nakamura; Koyo Nishida; Mikiro Nakashima; Mitsuru Hashida; Shigeru Kawakami; Hitoshi Sasaki
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 9.  mRNA vaccines in the prevention and treatment of diseases.

Authors:  Yangzhuo Gu; Jiangyao Duan; Na Yang; Yuxin Yang; Xing Zhao
Journal:  MedComm (2020)       Date:  2022-08-25

10.  Development of a DNA Vaccine for Melanoma Metastasis by Inhalation Based on an Analysis of Transgene Expression Characteristics of Naked pDNA and a Ternary Complex in Mouse Lung Tissues.

Authors:  Yukinobu Kodama; Mikiro Nakashima; Tadayuki Nagahara; Natsuko Oyama; Junya Hashizume; Hiroo Nakagawa; Hitomi Harasawa; Takahiro Muro; Tomoaki Kurosaki; Chikamasa Yamashita; Mitsuru Hashida; Takashi Kitahara; Hitoshi Sasaki; Shigeru Kawakami; Tadahiro Nakamura
Journal:  Pharmaceutics       Date:  2020-06-11       Impact factor: 6.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.